Brief: Vivos Therapeutics Q2 Net Income USD -1.93 Million
14/08/2024 21:05
Aug 14 (Reuters) - Vivos Therapeutics Q2 gross profit USD 2.651 million. * Q2 basic EPS USD -0.6 * Q2 operating expenses USD 4.587 million * Q2 operating income USD -1.936 million
Recent news on Vivos Therapeutics
See all newsBrief: Vivos Therapeutics Closes Acquisition Of Stake In Sod Sciences And 50% Interest In Pseudohypoxia Test, Opening A Potential Path To Access More Than 325,000 New Patients Through The Aha Channel
Brief: Vivos Therapeutics - Audit Reports For Fy2025 And Fy2024 Include Substantial Doubt About Going Concern
Brief: Vivos Therapeutics And South Palm Cardiovascular Associates Sign Definitive Agreements To Launch Regional Sleep Testing And Treatment Center
Vivos Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary
Vivos Therapeutics Q2 revenue rises 35% on service growth